On the other hand, ReDisX discovered a subpopulation within RA that shows statistically significant downregulation of GZMB. So, ReDisX helps to provide additional information on the same dataset wherein the drug treatment labeling is limited to indicate that precision information. The gene discussed is GZMB; the disease is rheumatoid arthritis.